Topics
Glioblastoma | Treatment | Targeted therapy | CC-115
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > CC-115
Rudra Gupta T, Polley MC, Redd R, Lee EQ, Arrillaga-Romany I,
Gilbert MR, Tan Y, Touat M, Drappatz J, Welch MR, Galanis E,
Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D,
Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR,
Batchelor TT, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL,
Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Aizer A, Doherty
L, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Ligon KL,
Weller M, Mehta MP, Wen PY, Trippa L, Rahman R.
Treatment
Effect Reanalysis of the Randomized Individual Screening Trial of
Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma
With External Control Data.
J
Clin Oncol. 2026 May 22:JCO2501586. doi:
10.1200/JCO-25-01586. PMID:
42172567. Trial
registration ID: NCT02977780˰
ˍ